MENS:NASDAQJyong Biotech Ltd. analysis
Data as of Aug 26, 2026 - not real-time
- Latest price
- $2.23
- Risk: high
- 9/10High risk
Summary
Jyong Biotech Ltd. is priced at $2.23 and its moving averages line up in bearish order, the shorter trailing the longer. Relative strength is 56.8 — neutral — and the MACD signal is bullish. Recent trading has carved out support near $1.91 and resistance around $2.47.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 66.8%, a beta of 2.02 and a maximum drawdown of 97.8%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 66.8%, a beta of 2.02 and a maximum drawdown of 97.8%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
Top market events
- TAIPEI, July 27, 2026 /PRNewswire/ -- Jyong Biotech Ltd.
- Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity And Reaffirms Strategic Focus On Global...
- New Taipei City, Taiwan, July 23, 2026 GLOBE NEWSWIRE -- Jyong Biotech Ltd.
Market outlook
Short term
< 1 yearNeutral
Model confidence2/102 out of 10
Key factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 6.34
- MACD momentum is positive
Medium term
1–3 yearsNeutral
Model confidence1/101 out of 10
Key factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 6.34
- 30-day volatility of 66.8%
Long term
> 3 yearsNeutral
Model confidence1/101 out of 10
Key factors
- 30-day volatility of 66.8%
- Beta of 2.02 versus the benchmark
- Positive free cash flow
Key metrics
Financial health
ROA-12.01%
P/B Ratio-6.6
Op. Cash Flow$-3041000
Free Cash Flow$4.4M
Industry P/E31.2
Technical analysis
TrendBearish
RSI56.8
Support$1.91
Resistance$2.47
MA 20$2.10
MA 50$2.11
MA 200$6.34
MACDBullish
VolumeDecreasing
Fear & Greed Index93.39
Valuation
Fair Value$0.51
GradeFair
TypeBlend
Risk assessment
Beta2.02
Volatility66.84%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.